Contact

Representative before the EPO

Company dna cabinet lavoix
no operation time available
1124.75
3 offices
active in Legal Services

We have observed 1 EP application Gaëlle Jan has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 24, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11802949

ROBO1-FC FUSION PROTEIN FOR USE IN THE TREATMENT OF HEPATOCARCINOMA

IPC classification:
A61K 38/18, C07K 14/475
Applicant:
Sanofi, S.A.
Agent:
Gaëlle Jan, Cabinet Lavoix
Agent:
Elsa Martin-Touaux, Sanofi
Status:
PATENT GRANTED

Please Sign in to use this feature